Corient IA LLC Makes New $524,000 Investment in UnitedHealth Group Incorporated $UNH

Key Points

• Corient IA LLC acquired 1,000 shares of UnitedHealth Group for approximately $524,000 as reported in a recent SEC filing.
• CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group for about $179,645, reducing his ownership by 5.36%.
• Analysts have revised ratings and target prices for UnitedHealth Group, with Deutsche Bank lowering its target from $521 to $362 and a mixed consensus rating ranging from sell to buy.

Corient IA LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,000 shares of the healthcare conglomerate's stock, valued at approximately $524,000.

Other large investors have also bought and sold shares of the company. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group in the fourth quarter valued at about $26,000. Bayforest Capital Ltd raised its holdings in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its holdings in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares in the last quarter. Kapitalo Investimentos Ltda acquired a new position in UnitedHealth Group during the 4th quarter worth $41,000. Finally, Copia Wealth Management acquired a new position in UnitedHealth Group during the 4th quarter worth $42,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH traded down $4.72 during mid-day trading on Tuesday, hitting $303.77. The stock had a trading volume of 22,226,972 shares, compared to its average volume of 23,411,996. The company's 50 day simple moving average is $289.03 and its 200 day simple moving average is $394.17. The stock has a market cap of $275.12 billion, a price-to-earnings ratio of 13.16, a PEG ratio of 1.99 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the prior year, the company earned $6.80 EPS. UnitedHealth Group's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.9%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Hsbc Global Res downgraded UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Mizuho cut their price target on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. TD Cowen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a research note on Monday, May 19th. Royal Bank Of Canada cut their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Finally, Erste Group Bank cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Fifteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $367.71.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.